Gosogliptin
Gosogliptin is a potent, selective DPP-4 inhibitor that elevates active incretin levels (GLP-1, GIP) to enhance glucose-dependent insulin secretion. It is used in research for studying type 2 diabetes mechanisms and has demonstrated efficacy in both in vitro enzymatic assays and in vivo animal models.
Product Specifications
CAS Number
869490-23-3
Product Name Alternative
Gosogliptin, DPP-IV, PF734200, PF-734200, PF 734200, PF00734200, PF-00734200, PF 00734200
Field of Research
Protein Biochemistry
Purity
99.74% (May vary between batches)
Solubility
DMSO:80 mg/mL (218.33 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (13.65 mM)
Smiles
C (=O) ([C@@H]1C[C@@H] (CN1) N2CCN (CC2) C=3N=CC=CN3) N4CC (F) (F) CC4
Molecular Formula
C17H24F2N6O
Molecular Weight
366.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
038598-FITC 200 µL
MRPL45, CT (MRPL45, 39S ribosomal protein L45, mitochondrial) (FITC) discontinued
Sign In for Pricing
View Details ![2-[4- (4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl) phenyl]butyric Acid Ethyl Ester](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
414717 250 mg
2-[4- (4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl) phenyl]butyric Acid Ethyl Ester
Sign In for Pricing
View Details